Cargando…

Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients

AIMS: There are previous studies on quality of life (QoL) in cardiac resynchronization therapy (CRT) patients; however, there are no data with the short EuroQol-five dimensions (EQ-5D) questionnaire predicting outcomes. We aimed to assess the predictive role of baseline QoL and QoL change at 6 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Klaudia Vivien, Széplaki, Gábor, Perge, Péter, Boros, András Mihály, Kosztin, Annamária, Apor, Astrid, Molnár, Levente, Szilágyi, Szabolcs, Tahin, Tamás, Zima, Endre, Kutyifa, Valentina, Gellér, László, Merkely, Béla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123937/
https://www.ncbi.nlm.nih.gov/pubmed/29182734
http://dx.doi.org/10.1093/europace/eux342
_version_ 1783352933574770688
author Nagy, Klaudia Vivien
Széplaki, Gábor
Perge, Péter
Boros, András Mihály
Kosztin, Annamária
Apor, Astrid
Molnár, Levente
Szilágyi, Szabolcs
Tahin, Tamás
Zima, Endre
Kutyifa, Valentina
Gellér, László
Merkely, Béla
author_facet Nagy, Klaudia Vivien
Széplaki, Gábor
Perge, Péter
Boros, András Mihály
Kosztin, Annamária
Apor, Astrid
Molnár, Levente
Szilágyi, Szabolcs
Tahin, Tamás
Zima, Endre
Kutyifa, Valentina
Gellér, László
Merkely, Béla
author_sort Nagy, Klaudia Vivien
collection PubMed
description AIMS: There are previous studies on quality of life (QoL) in cardiac resynchronization therapy (CRT) patients; however, there are no data with the short EuroQol-five dimensions (EQ-5D) questionnaire predicting outcomes. We aimed to assess the predictive role of baseline QoL and QoL change at 6 months after CRT with EQ-5D on 5-year mortality and response. METHODS AND RESULTS: In our prospective follow-up study, 130 heart failure (HF) patients undergoing CRT were enrolled. Clinical evaluation, echocardiography, and EQ-5D were performed at baseline and at 6 months of follow–up, continued to 5 years. Primary endpoint was all-cause mortality at 5 years. Secondary endpoints were (i) clinical response with at least one class improvement in New York Heart Association without HF hospitalization and (ii) reverse remodelling with 15% reduction in left ventricular end-systolic volume at 6 months. Fifty-four (41.5%) patients died during 5 years, 85 (65.3%) clinical responders were identified, and 63 patients (48.5%) had reverse remodelling. Baseline issues with mobility were associated with lower response [odds ratio (OR) 0.36, 95% confidence interval (CI) 0.16–0.84; P = 0.018]. Lack of reverse remodelling correlated with self-care issues at baseline (OR 0.10, 95% CI 0.01–0.94; P = 0.04). Furthermore, self-care difficulties [hazard ratio (HR) 2.39, 95% CI 1.17–4.86; P = 0.01) or more anxiety (HR 1.51, 95% CI 1.00–2.26; P = 0.04) predicted worse long-term survival. At 6 months, mobility (HR 3.95, 95% CI 1.89–8.20; P < 0.001), self-care (HR 7.69, 95% CI 2.23–25.9; P = 0.001), or ≥ 10% visual analogue scale (VAS) (HR 2.24, 95% CI 1.27–3.94; P = 0.005) improvement anticipated better survival at 5 years. CONCLUSION: EuroQol-five dimension is a simple method assessing QoL in CRT population. Mobility issues at baseline are associated with lower clinical response, whereas self-care issues predict lack of reverse remodelling. Problems with mobility or anxiety before CRT and persistent issues with mobility, self-care, and VAS scale at 6 months predict adverse outcome.
format Online
Article
Text
id pubmed-6123937
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-61239372018-09-10 Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients Nagy, Klaudia Vivien Széplaki, Gábor Perge, Péter Boros, András Mihály Kosztin, Annamária Apor, Astrid Molnár, Levente Szilágyi, Szabolcs Tahin, Tamás Zima, Endre Kutyifa, Valentina Gellér, László Merkely, Béla Europace Clinical Research AIMS: There are previous studies on quality of life (QoL) in cardiac resynchronization therapy (CRT) patients; however, there are no data with the short EuroQol-five dimensions (EQ-5D) questionnaire predicting outcomes. We aimed to assess the predictive role of baseline QoL and QoL change at 6 months after CRT with EQ-5D on 5-year mortality and response. METHODS AND RESULTS: In our prospective follow-up study, 130 heart failure (HF) patients undergoing CRT were enrolled. Clinical evaluation, echocardiography, and EQ-5D were performed at baseline and at 6 months of follow–up, continued to 5 years. Primary endpoint was all-cause mortality at 5 years. Secondary endpoints were (i) clinical response with at least one class improvement in New York Heart Association without HF hospitalization and (ii) reverse remodelling with 15% reduction in left ventricular end-systolic volume at 6 months. Fifty-four (41.5%) patients died during 5 years, 85 (65.3%) clinical responders were identified, and 63 patients (48.5%) had reverse remodelling. Baseline issues with mobility were associated with lower response [odds ratio (OR) 0.36, 95% confidence interval (CI) 0.16–0.84; P = 0.018]. Lack of reverse remodelling correlated with self-care issues at baseline (OR 0.10, 95% CI 0.01–0.94; P = 0.04). Furthermore, self-care difficulties [hazard ratio (HR) 2.39, 95% CI 1.17–4.86; P = 0.01) or more anxiety (HR 1.51, 95% CI 1.00–2.26; P = 0.04) predicted worse long-term survival. At 6 months, mobility (HR 3.95, 95% CI 1.89–8.20; P < 0.001), self-care (HR 7.69, 95% CI 2.23–25.9; P = 0.001), or ≥ 10% visual analogue scale (VAS) (HR 2.24, 95% CI 1.27–3.94; P = 0.005) improvement anticipated better survival at 5 years. CONCLUSION: EuroQol-five dimension is a simple method assessing QoL in CRT population. Mobility issues at baseline are associated with lower clinical response, whereas self-care issues predict lack of reverse remodelling. Problems with mobility or anxiety before CRT and persistent issues with mobility, self-care, and VAS scale at 6 months predict adverse outcome. Oxford University Press 2018-09 2017-11-22 /pmc/articles/PMC6123937/ /pubmed/29182734 http://dx.doi.org/10.1093/europace/eux342 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research
Nagy, Klaudia Vivien
Széplaki, Gábor
Perge, Péter
Boros, András Mihály
Kosztin, Annamária
Apor, Astrid
Molnár, Levente
Szilágyi, Szabolcs
Tahin, Tamás
Zima, Endre
Kutyifa, Valentina
Gellér, László
Merkely, Béla
Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
title Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
title_full Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
title_fullStr Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
title_full_unstemmed Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
title_short Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
title_sort quality of life measured with euroqol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123937/
https://www.ncbi.nlm.nih.gov/pubmed/29182734
http://dx.doi.org/10.1093/europace/eux342
work_keys_str_mv AT nagyklaudiavivien qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT szeplakigabor qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT pergepeter qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT borosandrasmihaly qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT kosztinannamaria qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT aporastrid qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT molnarlevente qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT szilagyiszabolcs qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT tahintamas qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT zimaendre qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT kutyifavalentina qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT gellerlaszlo qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients
AT merkelybela qualityoflifemeasuredwitheuroqolfivedimensionsquestionnairepredictslongtermmortalityresponseandreverseremodellingincardiacresynchronizationtherapypatients